Study to Assess Safety and Efficacy of Treating Symptomatic, Ischemic, Chronic Congestive Heart Failure Patients with an LVEF of ≤40% with Fresh, Uncultured, Autologous, Adipose-derived Regenerative Cells Isolated from Lipoaspirate.

Abroad (travel likely)RecruitingPHASE2

Conditions

Myocardial Injury · LV Dysfunction · Coronary Artery Disease · Heart Failure

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

National Scientific Medical Center, Astana, Kazakhstan
Contact: Study coordinator (Anastassiya Ganina-Smelova, PhD) · anastassiya_smelova@mail.ru · +77024346421
Contact: Study coordinator (Aizhan Akhaeva, PhD) · akhaeva@mail.ru · +77075008522
Contact: Study coordinator (Ralf Roethoerl, Dr)

Study leads

Abay Baigenzhin, Prof Dr
Principal Investigator
National Scientific Medical Center
Ralf Rothoerl, Dr
Study Director
International Foundation of Medicine and Science

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

Ventricular Ejection Fraction · LVF · LV Dysfunction

Abroad (travel likely)Recruiting

Orange, United States · Pasadena, United States

Mechanisms And Prognosis of Stroke-Heart Syndrome

Stroke · Myocardial Injury · Heart Failure

Abroad (travel likely)Recruiting

Wuhan, China

Study of Sivelestat Sodium in OPCABG

Coronary Heart Disease · Coronary Artery Disease · Coronary Arterial Disease (CAD)

Abroad (travel likely)RecruitingPHASE2

Nantong, China

NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial

Ischemia Reperfusion Injury · Myocardial Injury · Acute Kidney Injury

Abroad (travel likely)RecruitingPHASE2

San Francisco, United States